Showing results (821-830 of 1,211) with videos related to
Sort By:
Pageof 122
European Journal of Heart Failure|November 6, 2022
Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trialAlexander Peikert, Brian L Claggett, KyungMann Kim, et al.JACC. Asia|December 14, 2023
Clinical Features of Heart Failure With Normal Ejection Fraction: Insights From the ASIAN-HF RegistryKanako Teramoto, Wouter Ouwerkerk, Wan Ting Tay, et al.European Heart Journal|September 2, 2014
Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trialFaiez Zannad, Gaetano M De Ferrari, Anton E Tuinenburg, et al.Journal of the American Heart Association|April 7, 2018
Genome-Wide Associations of Global Electrical Heterogeneity ECG Phenotype: The ARIC (Atherosclerosis Risk in Communities) Study and CHS (Cardiovascular Health Study)Larisa G Tereshchenko, Nona Sotoodehnia, Colleen M Sitlani, et al.Circulation|September 29, 2024
Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF TrialKieran F Docherty, Alasdair D Henderson, Pardeep S Jhund, et al.JACC. Heart Failure|April 15, 2025
Finerenone and New York Heart Association Functional Class in Heart Failure: The FINEARTS-HF TrialJohn W Ostrominski, Muthiah Vaduganathan, Brian L Claggett, et al.European Journal of Heart Failure|June 24, 2022
Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failureRiccardo M Inciardi, Matteo Pagnesi, Carlo M Lombardi, et al.JAMA|October 20, 2020
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical TrialPaul W Armstrong, Carolyn S P Lam, Kevin J Anstrom, et al.Circulation. Heart Failure|March 12, 2021
Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF AnalysisLuis E Rohde, Brian L Claggett, Emil Wolsk, et al.Journal of the American College of Cardiology|August 3, 2019
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection FractionJasper Tromp, Li Shen, Pardeep S Jhund, et al.Pageof 122